scholarly journals Biophysical characterization of two commercially available preparations of the drug containing Escherichia coli L-Asparaginase 2

2021 ◽  
Vol 271 ◽  
pp. 106554
Author(s):  
Talita Stelling de Araújo ◽  
Sandra M.N. Scapin ◽  
William de Andrade ◽  
Maíra Fasciotti ◽  
Mariana T.Q. de Magalhães ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Biophysical Characterization

scholarly journals Complementary substrate specificity and distinct quaternary assembly of the Escherichia coli aerobic and anaerobic β-oxidation trifunctional enzyme complexes

2019 ◽  
Vol 476 (13) ◽  
pp. 1975-1994 ◽  
Author(s):  
Shiv K. Sah-Teli ◽  
Mikko J. Hynönen ◽  
Werner Schmitz ◽  
James A. Geraets ◽  
Jani Seitsonen ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Kinetic Studies ◽  
Biophysical Characterization ◽  
Aerobic Conditions ◽  
Membrane Bound ◽  
Quaternary Assembly ◽  
Enzyme Complexes ◽  
Aerobic And Anaerobic ◽  
Long Chain

AbstractThe trifunctional enzyme (TFE) catalyzes the last three steps of the fatty acid β-oxidation cycle. Two TFEs are present in Escherichia coli, EcTFE and anEcTFE. EcTFE is expressed only under aerobic conditions, whereas anEcTFE is expressed also under anaerobic conditions, with nitrate or fumarate as the ultimate electron acceptor. The anEcTFE subunits have higher sequence identity with the human mitochondrial TFE (HsTFE) than with the soluble EcTFE. Like HsTFE, here it is found that anEcTFE is a membrane-bound complex. Systematic enzyme kinetic studies show that anEcTFE has a preference for medium- and long-chain enoyl-CoAs, similar to HsTFE, whereas EcTFE prefers short chain enoyl-CoA substrates. The biophysical characterization of anEcTFE and EcTFE shows that EcTFE is heterotetrameric, whereas anEcTFE is purified as a complex of two heterotetrameric units, like HsTFE. The tetrameric assembly of anEcTFE resembles the HsTFE tetramer, although the arrangement of the two anEcTFE tetramers in the octamer is different from the HsTFE octamer. These studies demonstrate that EcTFE and anEcTFE have complementary substrate specificities, allowing for complete degradation of long-chain enoyl-CoAs under aerobic conditions. The new data agree with the notion that anEcTFE and HsTFE are evolutionary closely related, whereas EcTFE belongs to a separate subfamily.

Biophysical characterization of highly active recombinant Gaussia luciferase expressed in Escherichia coli

2010 ◽  
Vol 1804 (9) ◽  
pp. 1902-1907 ◽  
Author(s):  
Tharangani Rathnayaka ◽  
Minako Tawa ◽  
Shihori Sohya ◽  
Masafumi Yohda ◽  
Yutaka Kuroda
Keyword(s):  
Escherichia Coli ◽  
Gaussia Luciferase ◽  
Biophysical Characterization ◽  
Highly Active

scholarly journals Expression of recombinant mouse cytosolic carboxypeptidase 6 in Escherichia coli

2020 ◽  
Vol 185 ◽  
pp. 04050
Author(s):  
Ruixue Wang ◽  
Hui-Yuan Wu
Keyword(s):  
Escherichia Coli ◽  
Family Member ◽  
Soluble Fraction ◽  
Bacterial Expression ◽  
Side Chains ◽  
Biophysical Characterization ◽  
Protein Substrates ◽  
Bacterial Lysates ◽  
Induction Temperature

Cytosolic carboxypeptidase 6 (CCP6) is a member of cytosolic carboxypeptidase (CCP) family that catalyze the removal of polyglutamate side chains from protein substrates. Biochemical and biophysical characterization of CCPs requires large quantities of purified proteins. However, no method describing the expression of any mammalian CCP family member from bacteria has been published to our best knowledge. After considerable efforts to improve the solubility of mammalian CCPs expressed in bacteria, including the optimization of induction temperature and by using different receptive cells, we were able to get less expression of mouse CCP6 in soluble fraction of bacterial lysates. We report in this article, the bacterial expression of CCP6 using Arctic Express (DE3) competent cells that co-express the chaperonin system GroEL and GroES from Oleispira antarctica. However, to achieve a large number of soluble target proteins, the expression conditions still need to be further optimized.

scholarly journals Biophysical characterization of two commercially available preparations of the drug containing Escherichia coli L-Asparaginase 2

2020 ◽  
Author(s):  
Talita Stelling de Araújo ◽  
Sandra M. N. Scapin ◽  
William de Andrade ◽  
Maira Fasciotti ◽  
Mariana T. Q. de Magalhães ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Active Site ◽  
Lymphoblastic Leukemia ◽  
Biophysical Characterization ◽  
E Coli ◽  
Terminal Loop ◽  
Hydrolysis Of

AbstractThe hydrolysis of asparagine and glutamine by L-asparaginase has been used to treat acute lymphoblastic leukemia for over four decades. Each L-asparaginase monomer has a long loop that closes over the active site upon substrate binding, acting as a lid. Here we present a comparative study two commercially available preparations of the drug containing Escherichia coli L-Asparaginase 2, performed by a comprehensive array of biophysical and biochemical approaches. We report the oligomeric landscape and conformational and dynamic plasticity of E. coli type 2 L-asparaginase (EcA2) present in two different formulations, and its relationship with L-aspartic acid, which is present in Aginasa, but not in Leuginase. EcA2 shows a composition of monomers and oligomers up to tetramers, which is mostly not altered in the presence of L-Asp. The N-terminal loop of Leuginase, which is part of the active site is flexibly disordered, but gets ordered as in Aginasa in the presence os L-Asp, while L-Glu only does so to a limited extent. Ion-mobility spectrometry–mass spectrometry reveals two conformers for the monomeric EcA2, one of which can selectively bind to L-Asp and L-Glu. Aginasa has higher resistance to in vitro proteolysis than Leuginase, and this is directly related to the presence of L-Asp.

Sign in / Sign up

Export Citation Format

Share Document